Latisse (bimatoprost) is the only FDA-approved product for promoting the growth of sparse eyelashes. It is manufactured by Allergan and is EXACTLY the same as the Allergan product Lumigan, which is used to treat glaucoma. Although Latisse is currently approved only for use on upper eyelid lashes, it has been shown to help grow lashes on the lower lids as well as the hairs of the eyebrows. Although scalp hair follicles are believed to be less responsive to Latisse, there are anecdotal reports of success in treating some types of bald spots of the scalp with this product.
Latisse is by no means the only product available that contains this class of ingredients. Latanoprost (Xalatan) and travoprost (Travatan), both of which are FDA-approved at this time only for use in glaucoma, are also available by doctor's prescription. Anectodal reports suggest that Travatan may even be more effective than Latisse for growing eyelash hair.
I have begun combining the application of these products with in-office medical microneedling to promote hair growth in men and women who have not responded sufficiently well to other conventional treatments for male and female pattern hair loss.